Rett Syndrome


Research from A.M. Coutinho and co-authors yields new data on genetics & genomics



Rett Syndrome Library
Library Home

This article was published in Life Science Weekly, which you can subscribe to online.

2007 AUG 28 -- Scientists discuss in "MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients" new findings in & genomics. According to a study from Oeiras, Portugal, "Mutations in the coding sequence of the methyl-CpG-binding protein 2 gene (MECP2), which cause Rett syndrome (RTT), have been found in male and female autistic subjects without, however, a causal relation having unequivocally been established. In this study, the MECP2 gene was scanned in a Portuguese autistic population, hypothesizing that the phenotypic spectrum of mutations extends beyond the traditional diagnosis of RTT and X-linked mental retardation, leading to a non-lethal phenotype in male autistic patients."

"The coding region, exon-intron boundaries, and the whole 3'UTR were scanned in 172 patients and 143 controls, by Detection of Virtually All Mutations-SSCP (DOVAM-S). Exon 1 was sequenced in 103 patients. We report 15 novel variants, not found in controls: one missense, two intronic, and 12 in the 3'UTR (seven in conserved nucleotides). The novel missense change, c.617G >C (p.G206A), was present in one autistic male with severe mental retardation and absence of language, and segregates in his maternal family. This change is located in a highly conserved residue within a region involved in an alternative transcriptional repression pathway, and likely alters the secondary structure of the MeCP2 protein. It is therefore plausible that it leads to a functional modification of MeCP2. MECP2 mRNA levels measured in four patients with 3'UTR conserved changes were below the control range, suggesting an alteration in the stability of the transcripts," wrote A.M. Coutinho and colleagues, .

The researchers concluded: "Our results suggest that MECP2 can play a role in autism etiology, although very rarely, supporting the notion that MECP2 mutations underlie several neurodevelopmental disorders."

Coutinho and colleagues published the results of their research in American Journal of Medical Genetics Part B (MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics Part B, 2007;144(4):475-83).

For additional information, contact A.M. Coutinho, Instituto Gulbenkian de Ciencia, Oeiras, Portugal.

The publisher of the American Journal of Medical Genetics Part B can be contacted at: Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.

Keywords: Portugal, Oeiras, Genetics & Genomics, Genetics.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2007, Life Science Weekly via NewsRx.com.